GeneOne Life Science, Inc. announced a private placement of 722,218 registered common stock at a price of KRW 3,420 per share for gross proceeds of KRW 2,469,985,560 on September 6, 2023. The transaction has been approved by the board of directors of the company. The company will issue shares through paid-in capital increase allocation method.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,375 KRW | -0.42% | +0.21% | -16.37% |
1st Jan change | Capi. | |
---|---|---|
-16.37% | 138M | |
+1.51% | 42.75B | |
+48.71% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- A011000 Stock
- News GeneOne Life Science, Inc.
- GeneOne Life Science, Inc. announced that it expects to receive KRW 2.46998556 billion in funding